Operating Income Summary of ScinoPharm Taiwan, Ltd.

ScinoPharm Taiwan, Ltd.'s latest annual operating income in 2023 was 314.49 Million TWD , down -19.75% from previous year.
ScinoPharm Taiwan, Ltd.'s latest quarterly operating income in 2024 Q2 was 71.14 Million TWD , down -53.14% from previous quarter.
ScinoPharm Taiwan, Ltd. reported an annual operating income of 446 Million TWD in 2022, up 44.36% from previous year.
ScinoPharm Taiwan, Ltd. reported an annual operating income of 308.95 Million TWD in 2021, down -17.27% from previous year.
ScinoPharm Taiwan, Ltd. reported a quarterly operating income of 71.14 Million TWD for 2024 Q2, down -53.14% from previous quarter.
ScinoPharm Taiwan, Ltd. reported a quarterly operating income of 31.83 Million TWD for 2024 Q3, down -55.25% from previous quarter.

Annual Operating Income Chart of ScinoPharm Taiwan, Ltd. (2023 - 2009)

Historical Annual Operating Income of ScinoPharm Taiwan, Ltd. (2023 - 2009)

Year	Operating Income	Operating Income Growth
2023	314.49 Million TWD	-19.75%
2022	446 Million TWD	44.36%
2021	308.95 Million TWD	-17.27%
2020	373.45 Million TWD	16.36%
2019	320.95 Million TWD	-42.51%
2018	558.32 Million TWD	-0.11%
2017	558.96 Million TWD	-35.62%
2016	868.27 Million TWD	15.82%
2015	749.7 Million TWD	34.01%
2014	559.44 Million TWD	-59.97%
2013	1.39 Billion TWD	10.98%
2012	1.25 Billion TWD	11.1%
2011	1.13 Billion TWD	-7.29%
2010	1.22 Billion TWD	4.84%
2009	1.16 Billion TWD	0.0%

Year	Operating Income	Operating Income Growth
2024 Q1	151.83 Million TWD	-20.69%
2024 Q2	71.14 Million TWD	-53.14%
2024 Q3	31.83 Million TWD	-55.25%
2023 Q2	68.99 Million TWD	25.65%
2023 Q4	191.44 Million TWD	349.68%
2023 Q3	42.57 Million TWD	-38.29%
2023 Q1	54.9 Million TWD	-56.45%
2023 FY	357.92 Million TWD	-19.75%
2022 Q3	78.84 Million TWD	-44.74%
2022 FY	446 Million TWD	44.36%
2022 Q2	142.68 Million TWD	45.02%
2022 Q1	98.39 Million TWD	43.26%
2022 Q4	126.09 Million TWD	59.93%
2021 Q3	5.63 Million TWD	-94.92%
2021 FY	308.95 Million TWD	-17.27%
2021 Q1	110.34 Million TWD	418.52%
2021 Q2	110.78 Million TWD	0.41%
2021 Q4	68.67 Million TWD	1119.64%
2020 Q2	206.45 Million TWD	350.7%
2020 Q4	21.28 Million TWD	-79.13%
2020 FY	373.45 Million TWD	16.36%
2020 Q3	101.95 Million TWD	-50.62%
2020 Q1	45.8 Million TWD	-19.96%
2019 Q2	61.55 Million TWD	-47.6%
2019 Q4	57.23 Million TWD	85.64%
2019 FY	320.95 Million TWD	-42.51%
2019 Q3	30.83 Million TWD	-49.91%
2019 Q1	117.45 Million TWD	-23.74%
2018 FY	558.32 Million TWD	-0.11%
2018 Q4	154.01 Million TWD	25.35%
2018 Q3	122.87 Million TWD	-23.23%
2018 Q2	160.04 Million TWD	31.84%
2018 Q1	121.39 Million TWD	21.79%
2017 Q3	151.61 Million TWD	75.51%
2017 FY	558.96 Million TWD	-35.62%
2017 Q2	86.38 Million TWD	-60.96%
2017 Q1	221.28 Million TWD	5.26%
2017 Q4	99.67 Million TWD	-34.26%
2016 Q1	195.38 Million TWD	-25.98%
2016 FY	868.27 Million TWD	15.82%
2016 Q4	210.22 Million TWD	-9.96%
2016 Q3	233.47 Million TWD	1.87%
2016 Q2	229.19 Million TWD	17.31%
2015 Q2	126.05 Million TWD	-10.63%
2015 FY	749.7 Million TWD	34.01%
2015 Q1	141.05 Million TWD	177.47%
2015 Q4	263.95 Million TWD	20.72%
2015 Q3	218.64 Million TWD	73.45%
2014 Q4	50.83 Million TWD	-55.2%
2014 Q3	113.47 Million TWD	-46.62%
2014 Q2	212.57 Million TWD	16.44%
2014 FY	559.44 Million TWD	-59.97%
2014 Q1	182.56 Million TWD	-35.34%
2013 Q4	282.32 Million TWD	4.57%
2013 FY	1.39 Billion TWD	10.98%
2013 Q1	388.39 Million TWD	-1.19%
2013 Q2	456.78 Million TWD	17.61%
2013 Q3	270 Million TWD	-40.89%
2012 Q2	198.94 Million TWD	-29.88%
2012 Q1	283.71 Million TWD	-18.0%
2012 Q4	393.08 Million TWD	2.47%
2012 Q3	383.59 Million TWD	92.81%
2012 FY	1.25 Billion TWD	11.1%
2011 Q4	345.99 Million TWD	17.34%
2011 FY	1.13 Billion TWD	-7.29%
2011 Q1	190.1 Million TWD	-36.57%
2011 Q2	302.47 Million TWD	59.11%
2011 Q3	294.86 Million TWD	-2.52%
2010 Q3	385.64 Million TWD	0.0%
2010 FY	1.22 Billion TWD	4.84%
2010 Q4	299.71 Million TWD	-22.28%
2009 FY	1.16 Billion TWD	0.0%

Peer Operating Income Comparison of ScinoPharm Taiwan, Ltd.

Name	Operating Income	Operating Income Difference
Grape King Bio Ltd	2.49 Billion TWD	87.404%
Standard Chem & Pharm CO., LTD.	1.25 Billion TWD	75.032%
Maywufa Company Ltd.	211.01 Million TWD	-49.034%
Lotus Pharmaceutical Co., Ltd.	4.9 Billion TWD	93.586%
LIWANLI Innovation Co., Ltd.	- TWD	-Infinity%
YungShin Global Holding Corporation	929.61 Million TWD	66.17%
PhytoHealth Corporation	-121.67 Million TWD	358.464%
SCI Pharmtech, Inc.	160.3 Million TWD	-96.189%
Formosa Laboratories, Inc.	674.97 Million TWD	53.407%
PharmaEssentia Corporation	- TWD	-Infinity%
Bora Pharmaceuticals Co., LTD.	5.24 Billion TWD	94.009%

Global Stocks Search

ScinoPharm Taiwan, Ltd. (1789.TW)

Operating Income Summary of ScinoPharm Taiwan, Ltd.

Annual Operating Income Chart of ScinoPharm Taiwan, Ltd. (2023 - 2009)

Historical Annual Operating Income of ScinoPharm Taiwan, Ltd. (2023 - 2009)

Peer Operating Income Comparison of ScinoPharm Taiwan, Ltd.